slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 65,761-65,790
Pages 3,679
Rows per page 30
Component
65,761-65,790 of 110,355
18
The slide displays trends for Loan Loss Reserve/Gross Loans, Nonperforming Assets, Loan Loss Reserve/NPLs, and Net Charge-Offs/Avg. Loans.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
19
The slide provides a clear breakdown of deposit types, balances, and percentages, along with qualitative commentary on deposit costs and drivers.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
21
Includes a footnote regarding bank-level data usage for 2017 and 2018.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
22
LTM data reflects Q2 2022.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
23
Includes footnotes regarding non-GAAP measures and Q2 2022 annualization.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
33
Includes LTM (Last Twelve Months) column and specific footnotes regarding loan loss provisions.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
34
Includes footnotes regarding specific accounting changes and credit events.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
36
The slide presents a company overview and a table of key financial metrics including loan origination volume, fulfillment services, unit counts, and purchase percentage.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
37
The slide presents data for Middletown, Jefferson, Myersville, Boonsboro, Hagerstown, and Waynesboro.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
02
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations 1 hit
04
The slide uses a timeline-style visualization for clinical trial phases.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
05
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
06
The slide uses a structured table format to summarize key product attributes.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
08
The slide uses a table structure to map clinical strategy to market opportunity.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
09
The slide uses a table format to link clinical trial progress with market opportunity (patient numbers) and medical need.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
10
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations 1 hit
11
The slide uses a three-column layout to show the individual strengths of the partners and the synergy of the combined therapy.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
The slide provides a scientific foundation for the CLDN6xCD3 bispecific antibody program.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a list-based structure to present three key pillars of the target's clinical profile.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
The slide compares the library against a benchmark (IMAB027) in terms of reactivity and cytotoxicity.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
01
Exhibit 99.1 indicates this is likely a public filing or investor relations document.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Setup1 hit
05
The slide uses a combination of real-world dosing data and HCP satisfaction surveys to argue that the current standard of care (Jakafi) is being used ineffectively, creating a market need.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
06
The slide uses a biological pathway diagram to explain the mechanism of action.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
Includes product packaging imagery and regulatory status summary.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
10
The slide uses a process flow diagram to represent clinical trial methodology.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
13
The slide uses three bar charts to illustrate clinical efficacy endpoints related to anemia in a specific patient population.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
16
The slide uses a biological process diagram to explain the mechanism of action.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
17
The slide compares two different clinical trial datasets (PERSIST-2 vs MOMENTUM) to highlight efficacy.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
19
Slide emphasizes clinical validation and market positioning via guideline inclusion.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Go-to-MarketLoop · Quick Win Big Bet1 hit
22
The slide highlights financial stability to support commercialization efforts.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit